The Core Model. A Collaborative Paradigm for the Pharmaceutical Industry and Global Health Care

Table of Contents

Part I 1. Introduction: the remarkable success story of the development of bortezomib 2. Lessons from the development of bortezomib: the Core Model

Part II 3. The "Core�: when innovation meets leadership 4. "The Bridge�: collaboration is the best catalyst to success 5. "The Periphery�: the efficient use of underused societal resources

Part III 6. Biopharmaceutical intellectual property, financial interests, and the Core Model 7. Global health care crisis, the pharmaceutical industry, and the Core Model 8. The Core Model, innovation, economic growth, development, and policy-making

Part IV 9. Conclusion: the Core Model: a novel economic theory 10. Epilogue: the Core Model and other industries

Authors

Ibis Sanchez Serrano President and Founder, The Core Model Corporation, S.A., Panama City, Panama. Ibis S�nchez-Serrano is a world-leading expert on global healthcare, pharmaceutical innovation, and translational science policy. He is a member of the Editorial Board of the journal Gender & the Genome and has written two books, The World's Health Care Crisis: From the Laboratory Bench to the Patient's Bedside (Elsevier, 2011) and The Core Model: A Collaborative Paradigm for the Pharmaceutical Industry and Global Health Care (Elsevier, 2019). Mr. S�nchez-Serrano has built a reputation amongst important international government bodies as an expert on the world's healthcare crisis and the relevant solutions. He's a frequent speaker on global health care and pharmaceutical development and received international recognitions for his work on global health care, including a "Fulbright Recognition Award� and media coverage including CNN, C-SPAN, UNIVISION, EFE Agency, Deutsche Presse Agentur. His research interests include Health Care, Pharmaceuticals, Biotechnology, Public Health, Academia-Industry Relationship, Drug Discovery and Development, Organization and Management of R&D.